|Articles|September 9, 2022
Meet the FDA Diversity Action Plan Guidance
Author(s)Science 37
In this whitepaper, Science 37's Diversity & Inclusion leaders share strategies on how to achieve diversity in clinical trials in order to adhere to the FDA's Guidance.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
4
ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
